Alpa Laboratories transfers oral solid dosage formulations unit to Ipca Laboratories

04 Oct 2014 Evaluate

Alpa Laboratories has transferred its oral solid dosage formulations manufacturing Unit-II situated at sector III, Pithampur, Dhar in state of Madhya Pradesh, to Ipca Laboratories. This transfer has taken place pursuant to both the BTA & the NCA been executed on October 01, 2014. The sale of the facility will enable the company in focusing on the growth of its well established business of Unit-I.

Earlier, the company subsequent to the shareholders approval dated April 04, 2014, has sold its Unit-II as a going concern on a slump sale basis to Ipca Laboratories. The company has received a consideration of Rs 64 crore towards the Business Transfer Agreement (BTA) as a going concern on a slump sale basis and a fee of Rs 10 lakh excluding taxes towards the Non Compete Agreement (NCA) from the Ipca.

Alpa Laboratories manufactures a spectrum of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products. These products are manufactured in various dosage forms such as injectables (vials/ampoules both liquid and dry), tablets, capsules, eye/ear drops, ointment and creams.

Alpa Lab Share Price

82.19 -1.96 (-2.33%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×